Title | Letters in Drug Design and Discovery |
Abbreviation | Lett. Drug Des. Discov. |
Publication Type | Journal |
Subject Area, Categories, Scope | Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4) |
h-index | 36 |
Overall Rank/Ranking | 19611 |
SCImago Journal Rank (SJR) | 0.192 |
Impact Score | 1.08 |
Publisher | Bentham Science Publishers B.V. |
Country | United Arab Emirates |
ISSN | 15701808 |
Best Quartile | Q3 |
Coverage History | 2005-2022 |
Letters in Drug Design and Discovery is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Letters in Drug Design and Discovery is 19611. According to SCImago Journal Rank (SJR), this journal is ranked 0.192. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 36. The best quartile for this journal is Q3.
The ISSN of Letters in Drug Design and Discovery journal is 15701808. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Letters in Drug Design and Discovery is cited by a total of 370 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Letters in Drug Design and Discovery is 1.08, which is computed in 2023 as per its definition. Letters in Drug Design and Discovery IF is increased by a factor of 0.1 and approximate percentage change is 10.2% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Letters in Drug Design and Discovery is 1.08. If the same upward trend persists, Impact IF may rise in 2023 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2022 | 1.08 |
2021 | 0.98 |
2020 | 1.10 |
2019 | 1.14 |
2018 | 0.93 |
2017 | 0.88 |
2016 | 1.23 |
2015 | 1.06 |
2014 | 0.85 |
Letters in Drug Design and Discovery has an h-index of 36. It means 36 articles of this journal have more than 36 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Letters in Drug Design and Discovery is 15701808. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Letters in Drug Design and Discovery is 19611. According to SCImago Journal Rank (SJR), this journal is ranked 0.192. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2022 | 0.192 |
2021 | 0.213 |
2020 | 0.223 |
2019 | 0.240 |
2018 | 0.207 |
2017 | 0.247 |
2016 | 0.313 |
2015 | 0.324 |
2014 | 0.241 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2022 | 19611 |
2021 | 17941 |
2020 | 17995 |
2019 | 16567 |
2018 | 17500 |
2017 | 15173 |
2016 | 13144 |
2015 | 12735 |
2014 | 15178 |
Letters in Drug Design and Discovery is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2005-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Letters in Drug Design and Discovery is Lett. Drug Des. Discov.. This abbreviation ('Lett. Drug Des. Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Letters in Drug Design and Discovery latest impact IF is 1.08. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.23 (2016) and 0.85 (2014), respectively, in the last 9 years. Moreover, its average IS is 1.03 in the previous 9 years.
The Letters in Drug Design and Discovery has an SJR (SCImago Journal Rank) of 0.192, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.324 in 2015 and the lowest being 0.192 in 2022. Furthermore, the average SJR of the Letters in Drug Design and Discovery over the previous 9-year period stands at 1.03.
The latest h-index of the Letters in Drug Design and Discovery is 36.
The Letters in Drug Design and Discovery is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The Letters in Drug Design and Discovery is currently ranked 19611 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 12735 in 2015 and its lowest position of 19611 in 2022.
The standard ISO4 abbreviation for the Letters in Drug Design and Discovery is Lett. Drug Des. Discov..
Letters in Drug Design and Discovery is classified as a journal that the Bentham Science Publishers B.V. publishes.
The Letters in Drug Design and Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Letters in Drug Design and Discovery is assigned the following International Standard Serial Numbers (ISSN): 15701808.
The best quartile for the Letters in Drug Design and Discovery is Q3 (2022).
The Letters in Drug Design and Discovery coverage history can be summarized as follows: 2005-2022.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
European Union Politics | journal | 2250 | SAGE Publications Ltd | 72 | 2.64 |
Qualitative Research | journal | 2108 | SAGE Publications Ltd | 86 | 3.97 |
Journal of Competition Law and Economics | journal | 14815 | Oxford University Press | 29 | 0.72 |
Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
Journal of Classical Sociology | journal | 13766 | SAGE Publications Ltd | 27 | 0.83 |
Archives of the Balkan Medical Union | journal | 23243 | Balkan medical union | 10 | 0.24 |
Built Environment | journal | 12797 | Alexandrine Press | 43 | 1.15 |
Expert Review of Clinical Pharmacology | journal | 5241 | Taylor and Francis Ltd. | 53 | 4.10 |
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 1.08 |
2021 | 0.98 |
2020 | 1.10 |
2019 | 1.14 |
2018 | 0.93 |
2017 | 0.88 |
2016 | 1.23 |
2015 | 1.06 |
2014 | 0.85 |